United States · FDA National Drug Code directory
Guaifenesin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71679-309_45395c54-4eb3-fd26-e063-6294a90a9f93
- Product NDC
- 71679-309
- Form
- TABLET
- Composition / generic term
- Guaifenesin
- Labeler
- Health Pharma USA LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20240207
- Source listing expiry
- 20261231
Source-listed ingredients
- GUAIFENESIN — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 38500 TABLET in 1 BOTTLE (71679-309-00) · 71679-309-00
- 200 TABLET in 1 BOTTLE (71679-309-02) · 71679-309-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →